These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11718585)
1. Patient treatment preferences and the 5-HT1B/1D agonists. Ryan RE Arch Intern Med; 2001 Nov; 161(21):2545-53. PubMed ID: 11718585 [TBL] [Abstract][Full Text] [Related]
2. Migraine and its treatment with 5-HT1B/1D agonists (triptans). Moriarty-Sheehan M J Am Acad Nurse Pract; 2002 Aug; 14(8):354-9; quiz 360-2. PubMed ID: 12242852 [TBL] [Abstract][Full Text] [Related]
3. Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). Marcus DA Arch Neurol; 2001 Jul; 58(7):1056-8. PubMed ID: 11448293 [TBL] [Abstract][Full Text] [Related]
4. The safety of triptans in the treatment of patients with migraine. Jamieson DG Am J Med; 2002 Feb; 112(2):135-40. PubMed ID: 11835952 [TBL] [Abstract][Full Text] [Related]
5. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Ferrari MD; Goadsby PJ; Roon KI; Lipton RB Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060 [TBL] [Abstract][Full Text] [Related]
6. Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV. MacGregor EA; Brandes J; Gendolla A; Giammarco R Curr Med Res Opin; 2004 Nov; 20(11):1777-83. PubMed ID: 15537478 [TBL] [Abstract][Full Text] [Related]
7. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Ferrari MD; Roon KI; Lipton RB; Goadsby PJ Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541 [TBL] [Abstract][Full Text] [Related]
8. Triptans: over the migraine. Cologno D; Mazzeo A; Lecce B; Mundi C; Petretta V; Casucci G; d'Onofrio F Neurol Sci; 2012 May; 33 Suppl 1():S193-8. PubMed ID: 22644202 [TBL] [Abstract][Full Text] [Related]
9. Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Géraud G; Keywood C; Senard JM Headache; 2003 Apr; 43(4):376-88. PubMed ID: 12656709 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of the 5-HT1B/1D receptor agonists. Tepper SJ; Rapoport AM; Sheftell FD Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the triptans. Mathew NT; Loder EW Am J Med; 2005 Mar; 118 Suppl 1():28S-35S. PubMed ID: 15841885 [TBL] [Abstract][Full Text] [Related]
12. [Triptans in migraine--here and now (15 years after they were implemented in therapy)]. Prusiński A; Rozniecki JJ Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S68-77. PubMed ID: 16419574 [TBL] [Abstract][Full Text] [Related]
14. Almotriptan: a review of its use in migraine. Keam SJ; Goa KL; Figgitt DP Drugs; 2002; 62(2):387-414. PubMed ID: 11817980 [TBL] [Abstract][Full Text] [Related]
15. Rizatriptan: a review of its efficacy in the management of migraine. Dooley M; Faulds D Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439 [TBL] [Abstract][Full Text] [Related]
18. Current perspectives on effective migraine treatments: are small clinical differences important for patients? Ferrari MD Drugs Today (Barc); 2003; 39 Suppl D():37-41. PubMed ID: 15071619 [TBL] [Abstract][Full Text] [Related]
19. What do patients with migraine want from acute migraine treatment? Lipton RB; Hamelsky SW; Dayno JM Headache; 2002 Jan; 42 Suppl 1():3-9. PubMed ID: 11966858 [TBL] [Abstract][Full Text] [Related]
20. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Tfelt-Hansen P; De Vries P; Saxena PR Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]